Singapore markets close in 1 hour 2 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.80+0.23 (+2.68%)
At close: 04:00PM EDT
8.83 +0.03 (+0.34%)
After hours: 06:45PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts13131313
Avg. Estimate-0.37-0.34-1.3-0.78
Low estimate-0.52-0.48-1.77-1.59
High estimate-0.1-0.2-0.680.16
Year ago EPS-0.36-0.24-1.03-1.3
Revenue estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts12121313
Avg. Estimate49.92M64.4M273.92M375.12M
Low estimate47M56.5M259.27M269M
High estimate68.94M79.63M300.5M433.08M
Year ago sales8.89MN/A157.17M273.92M
Sales growth (year/est)461.60%N/A74.30%36.90%
Earnings history30/03/202129/06/202129/09/202130/12/2021
Est. EPS-0.27-0.24-0.29-0.3
Actual EPS-0.36-0.24-0.33-0.1
Difference-0.090-0.040.2
Surprise %-33.30%0.00%-13.80%66.70%
EPS trendCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Current estimate-0.37-0.34-1.3-0.78
7 days ago-0.37-0.34-1.3-0.78
30 days ago-0.37-0.33-1.23-0.69
60 days ago-0.36-0.33-1.28-0.98
90 days ago-0.36-0.33-1.26-0.8
EPS revisionsCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1664
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.-2.80%N/AN/AN/A
Next qtr.-41.70%N/AN/AN/A
Current year-26.20%N/AN/AN/A
Next year40.00%N/AN/AN/A
Next 5 years (per annum)15.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A